1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ABCC8 CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA ABHD17B CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ABLIM2 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA ABRACL CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA AC003002.6 CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA AC003006.7 CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA AC006449.2 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA AC006486.9 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA AC008522.1 CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA AC009065.1 CTRPv2 pan-cancer AAC 0.16 7e-06
Download CSV